GO:0016853 isomerase activity: Mechanism, Genes

Isomerase activity (GO:0016853) is a molecular function defined as the catalysis of geometric or structural changes within one molecule, and isomerase is the systematic name for any enzyme of EC class 5. Unlike transferases or hydrolases, isomerases do not add or remove groups; they rearrange existing atoms to convert a substrate into a stereochemical or structural isomer. This class includes prolyl isomerases, which catalyze cis-trans isomerization of peptidyl-prolyl bonds, and protein disulfide isomerases, which catalyze thiol-disulfide exchange. Because these reactions are often rate-limiting in protein folding, isomerase activity is central to proteostasis and to the functional maturation of secreted and membrane proteins. For researchers, GO:0016853 is a compact annotation that captures a mechanistically diverse set of enzymes unified by intramolecular rearrangement. Prolyl isomerase activity accelerates the folding of carbonic anhydrase in vitro, showing that isomerization can be a limiting step in acquisition of native structure. Protein disulfide isomerase activity is released by activated platelets, demonstrating that isomerase function is not restricted to the endoplasmic reticulum and can participate in extracellular events. In skeletal muscle, the prolyl isomerase Pin1 contributes to systemic energy metabolism and exercise capacity by regulating SERCA activity, connecting a single isomerase to organism-level physiology. Isomerase activity also intersects with chaperone biology. PDI exhibits chaperone-like activity in the refolding of rhodanese and of a protein with no disulfide bonds, and its anti-chaperone activity depends on its chaperone activity. The chaperone activity of PDI is independent of its thioredoxin-like active site, indicating that isomerase and chaperone functions can be genetically and biochemically separated. Finally, corticosteroid side-chain isomerase activity in the mouse is under genetic control, providing an early example of heritable variation in an isomerase reaction. Together these findings make GO:0016853 a useful entry point for studying protein folding, redox biology, metabolism, and endocrine function.

In plain terms, isomerase activity means helping a molecule change its shape without changing its chemical formula. The QuickGO definition states that GO:0016853 is the catalysis of geometric or structural changes within one molecule, and that isomerase is the systematic name for any enzyme of EC class 5. This includes enzymes that interconvert cis and trans isomers, move a functional group within a molecule, or rearrange a carbon skeleton. The synonym other isomerase activity is used when a gene product has isomerase function that is not captured by a more specific child term.

Isomerase activity is important because it controls rate-limiting intramolecular rearrangements that determine whether a protein or metabolite reaches its functional form. Prolyl isomerization can limit the folding of carbonic anhydrase, and PDI-catalyzed disulfide rearrangement supports the refolding of rhodanese and other substrates. In skeletal muscle, Pin1-dependent regulation of SERCA activity influences systemic energy metabolism and exercise capacity, showing that a single isomerase can affect whole-body physiology. PDI released by activated platelets indicates a role in vascular and thrombotic processes. Because PDI chaperone activity can be separated from its thioredoxin-like active site, isomerase activity is also a genetically tractable node for dissecting folding versus redox functions. Heritable control of corticosteroid side-chain isomerase activity in mice further highlights the potential for isomerases to influence endocrine phenotypes.

The following genes and proteins represent major experimental models for studying GO:0016853 isomerase activity, based on the verified literature.

Isomerase activity is regulated at several levels. Genetic control is demonstrated by the heritable regulation of corticosteroid side-chain isomerase activity in the mouse, indicating that isomerase reactions can be subject to allelic variation. In skeletal muscle, Pin1 contributes to systemic energy metabolism and exercise capacity through regulation of SERCA activity, showing that physiological state and signaling pathways influence isomerase-dependent processes. Protein disulfide isomerase activity can be released by activated platelets, providing a mechanism for rapid extracellular deployment of isomerase function. At the protein level, the chaperone activity of PDI is independent of its thioredoxin-like active site, so post-translational modification or mutation of catalytic cysteines does not necessarily abolish all PDI functions. Anti-chaperone activity depends on chaperone activity, indicating that substrate binding and release are coupled to regulation of folding outcomes.

Prolyl isomerase Pin1 in skeletal muscles contributes to systemic energy metabolism and exercise capacity through regulating SERCA activity. This places GO:0016853 in the context of metabolic disease and muscle function, where altered isomerase activity could influence calcium handling and energy homeostasis. Experimental models that manipulate Pin1 or SERCA can test whether isomerase activity is causally linked to exercise capacity and metabolic phenotypes.

Protein disulfide isomerase activity is released by activated platelets, indicating that isomerase function can act extracellularly during platelet activation. This links GO:0016853 to thrombotic and vascular processes. Because PDI combines isomerase and chaperone activities, disease models may need to separate these functions to determine which activity drives a given vascular phenotype.

Prolyl isomerase activity accelerates the folding of carbonic anhydrase, and PDI chaperone-like activity supports the refolding of rhodanese and of a protein with no disulfide bonds. These findings connect isomerase activity to proteostasis and to diseases involving protein misfolding. The independence of PDI chaperone activity from its thioredoxin-like active site suggests that some folding-related phenotypes may persist even when catalytic isomerase activity is lost.

Genetic control of corticosteroid side-chain isomerase activity in the mouse demonstrates that isomerase reactions can influence steroid metabolism. This provides a model for studying how heritable variation in isomerase activity affects endocrine physiology. Such work can inform hypotheses about isomerase-related endocrine disorders, although direct human disease associations require further study.

Direct measurement of isomerase activity uses purified enzyme and a suitable substrate. Prolyl isomerase activity can be assayed by monitoring accelerated folding of carbonic anhydrase. Protein disulfide isomerase activity can be measured by thiol-disulfide exchange or by refolding of rhodanese. These assays provide biochemical evidence that a candidate gene product has GO:0016853 activity.

Because PDI combines isomerase and chaperone activities, chaperone assays are used to dissect function. PDI chaperone-like activity can be measured in the refolding of rhodanese and of a protein with no disulfide bonds. Anti-chaperone activity depends on chaperone activity, so both readouts should be monitored when interpreting PDI function. Active-site mutants can test whether chaperone activity is independent of the thioredoxin-like motif.

PDI isomerase activity is released by activated platelets, so platelet activation assays can measure extracellular isomerase function. Such experiments link GO:0016853 to thrombosis and vascular biology. Combining platelet activation with PDI inhibitors or active-site mutants can identify which activities are secreted and which are retained intracellularly.

Genetic control of corticosteroid side-chain isomerase activity in the mouse can be studied by linkage analysis and knockout models. In skeletal muscle, Pin1-dependent regulation of SERCA activity can be assessed in exercise and metabolism experiments. These models connect isomerase activity to whole-organism phenotypes and provide causal tests of gene function.

Researchers studying isomerase activity-related genes often need to determine whether a candidate gene is causally involved in a folding, metabolic, or vascular phenotype. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with rigor and reproducibility.

GO:0016853 isomerase activity defines a fundamental molecular function in which enzymes catalyze intramolecular rearrangements without changing the chemical formula of the substrate. The verified literature shows that isomerases such as prolyl isomerases and protein disulfide isomerases accelerate rate-limiting folding steps, combine catalysis with chaperone-like activities, and influence physiological processes ranging from skeletal muscle energy metabolism to platelet activation and steroid side-chain conversion. Because PDI chaperone activity can be separated from its thioredoxin-like active site, isomerase activity is a genetically tractable function that can be dissected with precise CRISPR models. For researchers, GO:0016853 provides a focused annotation for studying protein folding, redox biology, and metabolism. Experimental strategies that combine enzymatic assays, genetic models, and CRISPR-based perturbations can determine which phenotypes depend on isomerase catalysis versus substrate binding. EDITGENE supports this work with knockout, point-mutation, knock-in, overexpression, and screening services tailored to isomerase activity research.